Who Gets To Define the Future Of Cannabis Medicine? (Op-Ed)

Becoming a credible healthcare category does not require whole-plant cannabinoid medicine to become indistinguishable from conventional pharmaceuticals.” By Matthew Myro Rothman, EM2P2 and CannaLnx …